Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-01
1997-05-27
Dentz, Bernard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514 27, 514 42, 514 43, 536 173, 536 2911, 546183, A61K 31435, C07D47104
Patent
active
056332610
ABSTRACT:
Immunostimulting swainsonine derivatives and methods for their synthesis are provided.
REFERENCES:
Chemical Abstracts, vol. 106, No. 17, 27 Apr. 1987, abstract No. 138253y, S. Hashimoto et al., p. 673.
Chemistry Letters, No. 1, 1985, pp. 31-34, N. Yasuda et al., p. 33.
Tetrahedron, vol. 43, No. 13, 1987, pp. 3095-3108; G.N. Austin et al., pp. 3097, 3106.
Chemical Abstracts, vol. 104, No. 23, 9 Jun. 1986, abstract No. 207151, H. Tsutsumi et al, pp. 743-744, abstract.
Tetrahedron Letters, vol. 31, No. 2, 1990, pp. 169-170; W.A. Anderson et al, p. 170.
Tetrahedron Letters, vol. 33, No. 34, 18 Aug. 1992, pp. 4917-4920; Y. Chen et al. compound 2.
Copy of International Search Report prepared by the EPO as the ISA dated 02 Feb. 1993.
Dentz Bernard
Toronto Research Chemicals, Inc.
LandOfFree
Immunostimulating swainsonine analogs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunostimulating swainsonine analogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunostimulating swainsonine analogs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2329272